secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0000950170-24-114690
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kintara retracts Oct 17 CVR record date; CVRs to pre-reverse-split holders ahead of Oct 18 merger
--------------------------------------------------------------------------------

- CVRs will be issued to stockholders of record immediately prior to the 1-for-35 reverse split, not on Oct 17 as previously announced.
- Reverse split and merger with TuHURA expected to close Oct 18, subject to regulatory approval and remaining conditions.
- Each CVR entitles holder to aggregate of up to 53,897,125 shares of common stock upon milestone achievement, adjusted for reverse split.
- Kintara does not anticipate the correction will change which stockholders receive CVRs or the number received.
- Previously approved reverse split range was 1-for-20 to 1-for-40; final ratio set at 1-for-35.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000095017024114690/0000950170-24-114690-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000095017024114690/ktra-20241014.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-114690

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer